Evidence map›Paper›PMID 26088930›Full record

ArticleHaematologica2015

Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.

Soumeya Abed, Alisa Tubsuwan, Porntip Chaichompoo, In Hyun Park, Alice Pailleret, Aïssa Benyoucef, Lucie Tosca, Edouard De Dreuzy, Anais Paulard, Marine Granger-Locatelli and 9 more

Abstract readLetter
In one paragraph

Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Soumeya AbedCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Université Paris 7, France.
Alisa TubsuwanCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Porntip ChaichompooCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
In Hyun ParkDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Alice PailleretCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
Aïssa BenyoucefCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm U967 - CEA / DSV / IRCM, Fontenay Aux Roses Cedex, France.
Lucie ToscaHôpital Antoine Béclère, Service d'Histologie Embryologie Cytogénétique, "Assistance Publique - Hôpitaux de Paris", Clamart, France.
Edouard De DreuzyCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Université Paris 7, France.
Anais PaulardBluebirdbio, Cambridge, MA, USA.
Marine Granger-LocatelliCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
Francis RelouzatCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
Stéphane ProstCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
Gerard TachdjianHôpital Antoine Béclère, Service d'Histologie Embryologie Cytogénétique, "Assistance Publique - Hôpitaux de Paris", Clamart, France.
Suthat FucharoenThalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
George Q DaleyDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Emmanuel PayenCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France.
Stany ChrétienCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France.
Philippe LeboulchCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Genetics Division, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Leïla Maouche-ChrétienCEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France leila.maouche@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsHematopoietic Stem CellsImmunocompromised HostInduced Pluripotent Stem CellsMacacaMiceModels, AnimalEngraftment of cy-iPSC-derived hematopoietic cellsInduced pluripotent stem cellsNonhuman primate

Identifiers

PMID26088930
PMCPMC4591782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.